<DOC>
	<DOCNO>NCT00055523</DOCNO>
	<brief_summary>Purpose study test whether adalimumab induce clinical remission subject active Crohn 's disease compare placebo ( inactive substance )</brief_summary>
	<brief_title>A Study Human Anti-TNF Antibody Adalimumab Induction Clinical Remission Subjects With Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<mesh_term>Adalimumab</mesh_term>
	<criteria>Inclusion : Diagnosis Crohn 's disease CDAI score baseline 220 450 Normal laboratory parameter Willing able give inform consent Exclusion : Diagnosis ulcerative colitis Women pregnant breastfeed No previous use infliximab antiTNF antagonists No previous history tuberculosis listeria infection No previous history cancer successfully treat skin cancer</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2006</verification_date>
</DOC>